Jazz Pharmaceuticals (JAZZ): Handicapping Vyxeos - Bernstein
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 213.23 +3.58 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.65 | 52 Week High | $160.00 | |||
| Open | $212.19 | 52 Week Low | $95.80 | |||
| Day High | $217.57 | P/E | 39.63 | |||
| Day Low | $212.19 | EPS | $5.38 | |||
| Volume | 516,637 | |||||
